Polyamyna is developing advanced antimicrobial technologies to combat multi, extensive and pan-drug-resistant pathogenic microorganisms.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: St. John&s;s
State: Newfoundland
Zip:
Country: Canada
Polyamyna helps to develop next-generation antimicrobial technologies to prevent infections caused by deadly pathogens, especially ESKAPE bacteria. Their products includes advanced antimicrobial technologies and disinfectant technology. Their customer can contact them through online.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2019 | Grant | 2 | $380.8k |
Government of Newfoundland and Labrador National Research Council of Canada Industrial Research Assistance Program Government of Newfoundland and Labrador National Research Council of Canada Industrial Research Assistance Program |
1/2019 | Pre Seed Round | 1 | - |
Genesis Genesis |
2/2020 | Seed Round | 1 | $1M |
Sustainable Development Technology Canada Sustainable Development Technology Canada |
1/2019 | Pre Seed Round | 1 | - |
Genesis Genesis |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|